Clinical trials: Menstrual Migraine
Migraine, Migraine Disease
Evaluation of the Migraceutics® Phase-Specific Dietary Supplement Regimen on Quality of Life, Work Productivity, and Biomarkers in Adult Migraineurs: The Migraceutics® START Study
The purpose of this study is to evaluate the impact of the Migraceutics® phase-specific dietary supplement regimen on quality of life, work productivity, and biomarkers in adult migraineurs.
- Conditions
- Migraine, Migraine Disease, Migraine Disorder, Migraine Headache
- Trial name
- NCT07634146
- Testing
- Foundational dietary supplement, Luteal phase dietary supplement add-on, Migraine phase dietary supplement add-on
- Where
- United States
- Volunteers
- 920 people
- Sponsor
- Miracle Wellness LLC
Migraine, Migraine;Menstrual
Oral Contraceptive Pill Compared With Vitamin E in Women With Migraine
Open-label randomized controlled trial to study the efficacy of continuous daily use of ethinylestradiol/levonorgestrel (30/150 µg/day) compared with vitamin E (400 IU/day) in the treatment of women with menstrually-related and…
- Trial name
- WHATT (NCT04007874)
- Testing
- Ethinylestradiol/levonorgestrel, Vitamin E
- Where
- Netherlands
- Volunteers
- 360 people
- Sponsor
- Leiden University Medical Center
Menstrual Migraine
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
The purpose of this study is to evaluate the efficacy and safety of rimegepant when administered during the peri-menstrual period (PMP) for intermittent prevention of migraine in women who experience menstrual migraine attacks.
- Trial name
- NCT06641466
- Testing
- Rimegepant, Standard of Care
- Where
- 123 sites in United States, Argentina and 13 more
- Volunteers
- 723 people
- Sponsor
- Pfizer
Menstrual Migraine
A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine
The objective of this phase 2 Proof.of Concept study is to evaluate the efficacy and safety of Sepranolone (UC1010) in preventing menstrual migraine attacks in adult women with migraine occurring between Day -2 and Day 5 of the…
- Trial name
- APH204 (NCT04102995)
- Testing
- Sepranolone injection low dose, Sepranolone injection high dose
- Where
- 7 sites in Finland, Sweden
- Volunteers
- 86 people
- Sponsor
- Asarina Pharma
Migraine
A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches
This study is being conducted to evaluate the efficacy of a 91-day extended cycle oral contraceptive compared to placebo for decreasing the frequency and severity of menstrually-related migraine headaches.
- Trial name
- NCT00781456
- Testing
- 91-day Levonorgestrel Oral Contraceptive
- Where
- 22 sites in United States
- Volunteers
- 109 people
- Sponsor
- Duramed Research
Menstrual Migraine (MM)
Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
A migraine attack is a moderate or severe headache that usually occurs on one side of the head and is often throbbing or pulsating.
- Trial name
- ATO MM (NCT06806293)
- Testing
- Atogepant
- Where
- 95 sites in China, Czechia and 10 more
- Volunteers
- 468 people
- Sponsor
- AbbVie
Migraine
Prospective Survey of Menstrual Migraine & Prevention With Eletriptan
Women are followed prospectively for 3 months, recording headaches, other symptoms, and menstrual periods. Those with menstrual migraine are treated perimenstrually with eletriptan for 3 months.
- Trial name
- NCT00259649
- Testing
- eletriptan
- Where
- United States
- Volunteers
- 71 people, healthy volunteers welcome
- Sponsor
- University of Pittsburgh
Migraine, Migraine Disorders
Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)
This study was designed to determine efficacy of TREXIMET (sumatriptan/naproxen sodium), formerly known as TREXIMA compared to placebo for the treatment of a menstrual migraine.
- Trial name
- NCT00329355
- Testing
- sumatriptan succinate/naproxen sodium
- Where
- 35 sites in United States
- Volunteers
- 351 people
- Sponsor
- GlaxoSmithKline
Migraine
Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol. A Double-Blind, Randomised, Cross-Over Trial.
The purpose of this study is to determine whether transdermally administered 17-beta estradiol sequentially could reduce the number of, and severity of, menstrual migraine attacks.
- Trial name
- NCT00204074
- Testing
- 17-beta-estradiol (drug)
- Where
- Sweden
- Sponsor
- University Hospital, Linkoeping
Migraine
Study of the Molecular Genetics of Menstrual Migraine
The investigators hypothesize that genes that play a role in menstrual migraine can be identified using a well characterised migraine population and a comprehensive genome-wide association scan approach.
- Trial name
- NCT00904150
- Where
- United Kingdom
- Volunteers
- 585 people, healthy volunteers welcome
- Sponsor
- The City of London Migraine Clinic
Menstrual Migraines, Menstrual Bleeding
Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives.
This study will examine the combined effects of a continuous oral contraceptive (OC) regimen with supplemental estradiol therapy on headache severity and occurrence in subjects with documented Menstrually Associated Migraines…
- Conditions
- Menstrual Migraines, Menstrual Bleeding, Menstrual Spotting
- Trial name
- Estradiol/MAM (NCT01251263)
- Where
- United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Scott and White Hospital & Clinic
Frovatriptan, Menstrual Migraine
Frovatriptan and Menstrual Migraine
We are looking for women who suffer from menstrual migraine to participate in a 2-visit migraine brain imaging research study. Our goal is to see how the menstrual migraine brain's pain pathways function when the migraineur has…
- Trial name
- FROVA (NCT01114711)
- Where
- United States
- Volunteers
- 24 people
- Sponsor
- Mclean Hospital
Migraine, Menstrual Migraine
Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45
The goal of this clinical trial is to learn about how a migraine prevention medicine works for people who have migraines/headaches with their menstrual period.
- Conditions
- Migraine, Menstrual Migraine, Menstrually Related Migraine
- Trial name
- NCT06173661
- Testing
- Fremanezumab
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- Brigham and Women's Hospital
Migraines, Bleeding
Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free Intervals
This study will examine the combined effects of a continuous oral contraceptive (OC) regimen with supplemental frovatriptan therapy on headache severity and occurrence in subjects with documented Menstrually Associated Migraines…
- Conditions
- Migraines, Bleeding, Spotting
- Trial name
- MAM (NCT00700128)
- Testing
- frovatriptan
- Where
- United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Scott and White Hospital & Clinic
Migraine, Dysmenorrhea
Discussion on the Mechanism of Acupuncture on Patients with Paroxysmal Migraine Without Aura : a Randomized Controlled Clinical Trial
Background: Migraine is common but poorly managed with drugs. Acupuncture, a non-pharmacological approach, has shown promise, yet its mechanisms remain unclear.
- Trial name
- NCT06676670
- Testing
- real acupuncture
- Where
- China
- Volunteers
- 108 people, healthy volunteers welcome
- Sponsor
- Bo Huang
Migraine
Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) Headaches
In this open-label, multi-center study, patients were treated with frovatriptan for a maximum of 12 perimenstrual periods (PMPs).
- Trial name
- MAM (NCT01035983)
- Testing
- Frovatriptan 2.5 mg
- Where
- 5 sites in Germany, Hungary and 3 more
- Volunteers
- 550 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
Menstrual Migraine
Comparison of the Prophylactic Effect Between Acupuncture and Acupressure on Menstrual Migraine
This study is designed to make comparisons between acupuncture and acupressure for preventing menstrual migraine (MM). Whether acupuncture is superior to acupressure is the most interesting point of this study.
- Trial name
- NCT02592681
- Testing
- verum acupuncture, acupressure, control acupuncture
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- Western University, Canada
Menstrual Migraine
Detecting Auricular Points in MMG by a Novel APD ( APD-MMG )
This pilot study is designed to validate the diagnostic ability of a novel APD for auricular point detection among patients with menstrual migraine (MMG), as compared with an already commercialized device.
- Trial name
- NCT03702114
- Testing
- auricular point detection
- Where
- Hong Kong
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- The University of Hong Kong
Menstrual Migraine (MM) Headaches
Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine
Females 18 years of age or older with at least one year history of menstrual migraine (MM) headaches participated in a Phase 4 clinical trial to evaluate the efficacy of frovatriptan when used at the early stage (International…
- Trial name
- NCT00904098
- Testing
- Frovatriptan, Usual Care
- Where
- 21 sites in United States
- Volunteers
- 192 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company